Harm Reduction
interventions aimed at reducing the negative effects of health behaviors without necessarily extinguishing the problematic health behaviors completely
any positive change
Principle 1
accepts, for better or worse, that licit and illicit drug use is part of our world and chooses to work to minimize its harmful effects rather than simply ignore them or condemn them
Principle 2
understands drug use as a complex, multi faceted phenomenon that encompasses a continuum of behaviors from severe use to total abstinence and acknowledges that some ways of using drugs are clearly safer than others
Principle 3
establishes quality of individual and community life and well-being as the criteria for successful interventions and policies
Principle 4
calls for the non-judgemental, non-coercive provision of services and resources to people who use drugs and the communities in which they live in order to assist them in reducing harm
Principle 5
ensures that people who use drugs and those with a history of drug use routinely have a real voice in the creation of programs and policies designed to serve them
Principle 6
affirms people who use drugs themselves as the primary agents of reducing the harms of their drug use and seeks to empower them to share information and support each other in strategies
Principle 7
recongizes that the realities of povery, class, racism, social isolation, past trauma, sex based discrimination, and other inequalities affect people’s vulnerability to and capacity for effectively dealing with drug harm
Principle 8
does not minimize or ignore the real and tragic harm and danger that can be associated with drug use
Medications for Opioid Use Disorder
Methadone: agonist
- requires active withdrawal with no opioid 8-10 hours before
Buprenorphine: partial agonist
- requires active withdrawal with no opioid 6-12 hours before
Naltrexone: antagonist
How do OUD Medications reduce harm
What is the evidence based for OUD medications
MAT Act
waiver elimination for the prescribing of medications like buprenorpphine
Naloxone
What is it? opioid antagonist that binds to the opioid receptor and kicks off other opioids
- available as nasal spray, IM, subQ, IV
How does Naloxone reduce harm
What is the evidence based for Naloxone
What two naloxone products are OTC?
Narcan & Rivive
Syringe Service Programs
How do SSP reduce harm
What is the evidence based for SSP
How many SSP in Indiana?
12
Sterile Syringes in Pharmacies
pharmacists can dispense sterile syringes without a prescription but must maintain a record book:
- name
- address
- name and quantity of syringes
- date
- initials of RPh
YOU DO NOT NEED TO DOCUMENT REASON
Supervised Consumption Sites
How do SCS reduce harm